CONTINUE TO SITE >

OR WAIT 15 SECS

AMCPASCOAutoimmune DiseasesBiosimilarsEyecareImproving Ophthalmic Care Access and Treatment Among Aging AdultsMultiple SclerosisSecondary Progressive Multiple Sclerosis: Patient Impact and Coverage Implications for New Therapies

Business

Business StrategyConsumersDrug CostsDrug PipelineFormularyHealth ManagementHealth/Disease StrategyHospitals & ProvidersIndustry AnalysisPharmacyPolitics and PolicyPractice ManagementReimbursementTechnology

Clinical

Autoimmune DiseasesBiosimilarsDermatologyDiabetesEyecareLeukemia and LymphomaMental HealthObstetrics-Gynecology & Women's HealthOncologyOpioidsPediatricsPlaque PsoriasisSolid TumorsUrology

News

Media

Expert InterviewsMedical World NewsPodcasts

Conferences

Publications

Resources

Sponsored ResourcesSurveys

Subscribe

eNewsletterPrint Subscription

Advertise
Editorial
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Informations

Spotlight

AMCP
ASCO
Autoimmune Diseases
Biosimilars
Eyecare
Improving Ophthalmic Care Access and Treatment Among Aging Adults
Multiple Sclerosis
Secondary Progressive Multiple Sclerosis: Patient Impact and Coverage Implications for New Therapies

BusinessSee All >

Business Strategy
Consumers
Drug Costs
Drug Pipeline
Formulary
Health Management
Health/Disease Strategy
Hospitals & Providers
Industry Analysis
Pharmacy
Politics and Policy
Practice Management
Reimbursement
Technology

ClinicalSee All >

Autoimmune Diseases
Biosimilars
Dermatology
Diabetes
Eyecare
Leukemia and Lymphoma
Mental Health
Obstetrics-Gynecology & Women's Health
Oncology
Opioids
Pediatrics
Plaque Psoriasis
Solid Tumors
Urology

Advertise
Editorial
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Informations

HMOs strategize to sustain state share

May 1, 2003

Tracey Walker

HMO industry is currently in a state of flux or transition